Researchers team virtual reality with AI to train new surgeons

Machine learning can be combined with virtual or augmented reality to train surgery residents in sensitive spinal procedures.

Further, the researchers who demonstrated the technique showed their algorithms capable of finely distinguishing between junior- and senior-level surgeons by assessing their dexterity during the procedures.

The study was conducted at McGill University in Montreal and published online ahead of print in the Journal of Bone and Joint Surgery.

Vincent Bissonnette, MD, and colleagues enrolled 22 experienced surgeons and 19 trainees to perform a virtual hemilaminectomy, a minimally invasive procedure used to alleviate spinal compression.

The researchers recorded, at 20-millisecond intervals, the position, angle and force of simulated surgical instruments as the participants used these tools to remove simulated tissue.

From these metrics the team drew data with which to train five AI algorithms.

The best of these, a support vector iteration, differentiated the junior-level physicians from their senior-level counterparts with 97.6% accuracy.

This result suggests strong potential for a combined AI-virtual reality curriculum “to provide safer training and objective assessment of surgical skills, which could lead to improved patient care,” the authors conclude.

The study is available in full for free via the Ovid database.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.